SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-22-000338
Filing Date
2022-01-20
Accepted
2022-01-20 16:16:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cns_s3.htm S-3 194731
2 OPINION AND CONSENT OF SCHIFF HARDIN LLP cns_ex0501.htm EX-5.1 6954
3 CONSENT OF MALONEBAILEY, LLP cns_ex2301.htm EX-23.1 3250
  Complete submission text file 0001683168-22-000338.txt   205924
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-262262 | Film No.: 22542476
SIC: 2834 Pharmaceutical Preparations